WSHA Selects Incyte Diagnostics as an Industry Partner
Posted: Jan 29, 2014


The Washington State Hospital Association (WSHA) has selected Incyte Diagnostics to its Industry Partner Program.  The WSHA Industry Partner Program has a rigorous evaluation process that ensures its partners, in their respective industries, meet high standards of quality and service.  The WSHA contracts with a single vendor per industry.
Washington’s hospitals and health systems work hard to ensure access to safe, high quality, cost effective health care.  WSHA advocates on behalf of and in support of its members in their missions to improve the health of their communities.  The Industry Partner Program assists hospitals by identifying vendors that have passed their high standards for quality, service and integrity.   
“Incyte Diagnostics is proud to have earned the WSHA seal of approval,” explains Incyte Diagnostics’ President, Christopher J. Montague, M.D.  “Partnering with the WSHA will help Washington hospitals improve operational efficiencies and deliver the highest quality of pathology care to their communities.”

« back